Funding News: 18 December 2009
December 18, 2009
In This Issue:
-
* GrantsNet sponsorship
New Research Funding Programs
- Alliance for Cancer Gene Therapy (ACGT).
-
Young Investigator Award Research Grant
Alliance for Cancer Gene Therapy Inc. (ACGT) funds research aimed at furthering the development of gene therapy approaches to the treatment of cancer. To this end, ACGT offers its Young Investigator Award to qualified scientists at the tenure track assistant professor level and above. Deadline: 2010-01-04
- American Association for Laboratory Animal Science.
-
Grants for Laboratory Science (GLAS)
The American Association for Laboratory Animal Science (AALAS) Grants for the Laboratory Animal Science program, established in 2006, provides competitive 1-year grants for research to improve the health and welfare of laboratory animals. Examples of research interests are (1) environmental conditions, (2) housing and enrichment, (3) pain and distress, (4) health and welfare, (5) euthanasia, and (6) advancements in animal care and use. Applicants may be anyone experienced with the care and use of laboratory animals, independent of their education or scientific background, such as technicians, veterinarians, and research scientists. The principal investigator must be an AALAS member; however, collaboration with the broader scientific community is encouraged, and co-investigators are exempt from the AALAS membership requirement. The Scientific Advisory Committee oversees this program and issues awards of up to $50,000. Downloadable applications and instructions are available on www.aalas.org/glas and only electronically submitted applications will be accepted through 1 February 2010. Awardees will be notified by 30 April 2010, and funds will be disbursed in May. Deadline: 2010-02-01
- Bill and Melinda Gates Foundation.
-
We are continuing the mission set forth in the Grand Challenges in Global Health initiative by continuing to invest in solutions to further Grand Challenge 14: develop technologies that allow the assessment of multiple conditions and pathogens at point of care. Specifically, we seek to create a new class of point-of-care (POC) diagnostics that will be easy to use, low cost, and otherwise appropriate so that these new tools achieve significant impact and rapid uptake in resource-poor settings. In the developing world, tools are not available to easily and accurately assess an individual's health status, including their risk of various illnesses and treatment options. In addition, little information about the burden of disease is available to guide population-based health decisions. This critically impacts the care that people receive. A solution, according to studies conducted by the Diagnostics Forum, is to move toward a common POC diagnostic platform for global health. POC diagnostics are not intended only to be used in a laboratory or clinic by a trained user. They also need to be operated by minimally trained community health workers in limited infrastructure settings. The platform we envision will have the ability to assess multiple pathogens and health conditions using a set of common technical, logistical, and medical decision-making approaches. The combination of (1) a point-of-decision test and (2) a common platform will ultimately result in better health outcomes. The challenge for these POC diagnostic platforms for global health is to define and achieve the needed performance characteristics of rapid, accurate assessment of individuals' health status, including robust, simple-to-use technologies for achieving parallel, multipathogen, reliable, and valid clinical measures in developing-world settings. High-throughput approaches to genomics, proteomics, metabolomics, and the measurement of other analytes, coupled with novel technologies of miniaturization and multiplexing create the possibility of radically new ways to detect and diagnose health and disease states in individuals, even in remote or impoverished settings with limited infrastructure. The coupling of new and existing validated biomarker signatures with microfluidic platforms could place effective diagnostics within reach of unskilled users in the developing world. Deadline: 2010-02-16
- Department of Health and Human Services. National Institutes of Health
-
Dissemination and Implementation Research in Health (R03)
This funding opportunity announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, and refine effective and efficient methods, structures, and strategies to disseminate and implement research-tested health behavior change interventions and evidence-based prevention, early detection, diagnostic, treatment, and quality of life improvement services into public health and clinical practice settings. This FOA will use the National Institutes of Health Small Research Grant (R03) award mechanism and runs in parallel with FOAs of identical scientific scope, PAR-10-038 and PAR-10-040, which solicit applications under the Research Project Grant (R01) and the Exploratory/Developmental Grant (R21) award mechanisms. Budgets for direct costs of up to $50,000 per year and a project duration of up to 2 years may be requested for a maximum of $100,000 direct costs over a 2-year project period. Deadline: 2010-01-16; 2010-05-16; 2010-09-16
- Department of Health and Human Services. National Institutes of Health
-
Cancer Immunotherapy Trials Network (U01)
The purpose of this funding opportunity announcement (FOA) is to stimulate the conduct of early (phase 1 and phase 2) clinical trials in the area of cancer immunotherapy by forming a Cancer Immunotherapy Trials Network (CITN). The emphasis is on clinical trials of high-priority agents that were identified at the 2007 National Cancer Institute (NCI) immunotherapy agent workshop and on clinical trials using combinations of immunotherapy modalities and other agents. CITN will support a multi-investigator team assembled to bring new immunotherapy agents to the clinic. This support will be realized through a single award for a Central Operations and Statistical Center (COSC) of CITN. Whereas this FOA solicits applications specifically for the CITN COSC, the awardee team and their program directors/principal investigators will provide overall leadership and statistical and protocol coordinator support for the CITN program. COSC applicants must plan that CITN will include the following additional elements : (1) up to 25 institutions that will conduct the clinical trials as CITN member sites (supported through subcontracts within the COSC award); (2) support for tumor immunology laboratories that are associated with the member sites to conduct standardized immunomonitoring assays and biomarker and correlative studies related to the clinical trials; and (3) a data-coordinating service that will be provided by a unit operated by NCI (which remains beyond the scope of solicited applications). NCI intends to fund a single U01 and to commit approximately $1.6 million in total costs in 2010 and $14 million total costs over a 5-year period of the award. Beyond this award, NCI has committed $3 million for initial data management, capitation, and specimen collection costs to support these functions for CITN over the initial 2 years of the award period. Deadline: 2010-01-19
- Department of Health and Human Services. National Institutes of Health
-
Clinical Trial Planning Grants for Critical Illness and Injury in Aging (R34)
This funding opportunity announcement (FOA) issued by the National Institute on Aging encourages Clinical Trial Planning Grant (R34) applications to develop research protocols for phase 3 and 4 clinical trials related to critical illness and injury in aging. The planning grant mechanism is intended to permit early peer review of the rationale and design of the proposed phase 3 or 4 clinical trial and to support development of a research team, tools for data management and research oversight, recruitment strategies, detailed protocol, and the Manual of Procedures, and other essential components necessary for a competitive clinical trial application. This FOA is not designed for collecting preliminary data or conducting pilot studies in support of the scientific rationale for a clinical trial. This FOA will utilize the Clinical Trial Planning Grant (R34) mechanism and runs in parallel with PA-10-042, which encourages applications under the R01 Research Project grant mechanism, PA-10-043, which encourages applications under the R03 Small Research Grant mechanism, and PA-10-044, which encourages applications under the R21 Exploratory/Developmental grant mechanism. The total project period for an application submitted in response to this funding opportunity is 1 year. Direct costs of up to $100,000 may be requested for the 1-year period. Deadline: 2010-02-16; 2010-06-16; 2010-10-16
- Department of Health and Human Services. National Institutes of Health
-
Research on Integrity in Collaborative Research (R21)
This funding opportunity announcement (FOA) issued by the National Center for Research Resources, the Fogarty International Center, the National Institute of Biomedical Imaging and Bioengineering, Office of Research Integrity (ORI), and the Office for Human Research Protections encourages research grant applications from institutions/organizations that propose to study research integrity as it relates to collaborative interactions and/or activities. The R21 exploratory/developmental mechanism will be used to foster research where there are few published data and where problem areas that would benefit from further investigation could be identified. Applications must address the influence of collaborative interactions and/or activities on research integrity in at least one of the following areas that are of particular interest to ORI and the National Institutes of Health (NIH): (1) the clarification of community norms, and standards; (2) the effectiveness of self-regulation; (3) the societal, organizational, group, or individual factors that affect integrity in research, both positively and negatively; or (4) the impacts of nonadherence to accepted codes of conduct. The proposed project must challenge existing paradigms and be developed around an innovative hypothesis or address critical barriers to progress in understanding the multiple factors that underlie deviation from integrity in collaborative research. Proposals must have clear relevance to biomedical, behavioral health sciences, or health services research. Applicants are encouraged to take into consideration problems or issues that have relevance to the specific interests of ORI or NIH institutes and centers. This FOA will utilize the R21 grant mechanism. Funding for fiscal year 2010 is anticipated to be $850,000 in total costs to support two or three new R21 awards. The total project period for an application submitted in response to this funding opportunity may not exceed 2 years. Direct costs are limited to $275,000 over a 2-year period, with no more than $200,000 in direct costs allowed in any single year. The R21 is not renewable Deadline: 2010-03-07
- Department of Health and Human Services. National Institutes of Health
-
Development of New Tools for Computational Analysis of Human Microbiome Project Data (R21)
The National Institutes of Health (NIH) solicits applications to develop new and improved computational tools for the analysis, interpretation, and validation of data generated from the Human Microbiome Program. This funding opportunity announcement will utilize the NIH Exploratory/Development (R21) award mechanism and runs in parallel with an FOA of identical scientific scope, RFA-RM-09-020, that solicits applications under the R01 mechanism. The amount of $2.5 million is available in fiscal year 2010 for this FOA and the parallel R01 FOA in combination. It is anticipated that two to five R01 grants (of duration up to 3 years) and two to four R21 grants will be awarded. Budgets will be negotiated to optimize the number of awards that can be made. Awards issued under this FOA are contingent on the availability of funds and the receipt of a sufficient number of meritorious applications. The total project period for an application submitted in response to this funding opportunity may not exceed 2 years. Direct costs are limited to $150,000 per year for a 2-year period. Deadline: 2010-01-04
- Department of Health and Human Services. National Institutes of Health
-
This funding opportunity announcement (FOA) will support meritorious research projects that involve secondary data analyses or development of statistical methodology using existing genome-wide data, relevant to human dental or craniofacial conditions or traits. This FOA will utilize the National Institutes of Health Small Research Grant (R03) award mechanism. The total amount awarded will depend on the scientific merit of applications and the funds available in the National Institute of Dental and Craniofacial Research general funding pool. Budgets for direct costs of up to $200,000 per year and a project duration of up to 2 years may be requested for a maximum of $300,000 direct costs over a 2-year project period. Deadline: 2010-02-16; 2010-06-16; 2010-10-16
- Department of Health and Human Services. National Institutes of Health
-
Seek, Test, and Treat: Addressing HIV in the Criminal Justice System (R01)
This initiative solicits R01 applications to empirically test the seek, test, and treat paradigm in criminal justice populations. The seek, test, and treat model involves (1) reaching out to high-risk, hard-to-reach groups that have not been recently tested (seek); (2) engaging them in HIV testing (test); and (3) initiating, monitoring, and maintaining Highly Active AntiRetroviral Treatment (HAART) for those testing positive (treat). Researchers are encouraged to develop, implement, and test strategies to increase HIV testing and the provision of HAART to HIV seropositive individuals involved with the criminal justice system, with particular focus on continuity of HAART during and after community re-entry following incarceration. Key outcome measures include linkage to care (e.g., seen at care center post-release) and viral suppression (e.g., proportion with undetectable viral load 6 months or more after initiation of antiretroviral treatment). Applications responsive to this funding opportunity announcement (FOA) may propose intervention research at the individual, organizational, or system level that leads to effective approaches for expanding access to HIV testing and HAART treatment in the criminal justice system and in community organizations working with criminal justice systems and populations. This FOA will utilize the R01 grant mechanism and encourages multiprincipal investigator applications and/or multisite studies. The National Institute on Drug Abuse, the National Institute of Mental Health, and the National Institute of Allergy and Infectious Diseases intend to commit $10.6 million to fund seven to nine new awards. Direct costs will vary with the scope of the project and may exceed over $500,000 per year if warranted by the scope. A project duration of up to 5 years may be requested. Deadline: 2010-03-02
- Department of Health and Human Services. National Institutes of Health
-
Prioritizing Molecular Targets for Cancer Prevention with Nutritional Combinations (R01)
This funding opportunity announcement (FOA), issued by the National Cancer Institute, and the Office of Dietary Supplements, of the National Institutes of Health (NIH), invites research applications to enhance our understanding about the dynamic interrelationship that exists between bioactive food components (and/or combinations thereof) and cancer prevention. Although much evidence exists that dietary components are linked to cancer prevention, the interactions among dietary bioactive compounds and food combinations remains underinvestigated. Applications are encouraged to consider either multiple dietary bioactive components, intact foods or multiple foods utilizing physiologically relevant concentrations of the agents. New genetic technologies may be employed to study the impact of dietary components on complex cellular and molecular networks, as part of the effort to better understand the basis for the multifaceted interactions of food components with cancer-prevention mechanisms. Specifically, applications that apply new, high-throughput genomic, epigenomic, proteomic, and metabolomic technologies to prioritize molecular targets of dietary components are highly encouraged. The sites of action that may be evaluated include carcinogen metabolism, DNA repair, cell proliferation, apoptosis, differentiation, hormonal regulation, energetics, inflammation, and/or angiogenesis. In addition, applications should either evaluate multiple molecular targets within a cancer process or multiple processes in order to prioritize which processes are most involved in bringing about a phenotypic change. It is hoped that advances in this area may assist in optimizing cancer prevention while minimizing potential toxicity due to food components. The resulting information will help define which foods or food components should be considered in isolation or in combination when developing dietary strategies to reduce cancer risk and/or modify tumor behavior. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received. Deadline: 2010-02-05; 2010-06-05; 2010-10-05
- Department of Health and Human Services. National Institutes of Health
-
Membrane Protein Production for Structure Determination (R01)
This funding opportunity announcement (FOA) solicits applications to develop innovative methods for membrane protein production so that the rate of membrane protein structure determination may be enhanced. Methods development for expression, solubilization, stabilization, purification, characterization, crystallization, and isotopic labeling of membrane proteins to enable the determination of their structures by electron microscopic, x-ray diffraction, nuclear magnetic resonance, mass spectrometry, and other biophysical techniques are emphasized. This FOA is a follow-on to the National Institutes of Health (NIH) Roadmap RFA-RM-07-003 with updates and modification of the mechanisms of grant support that are to be used. This FOA will utilize the R01 grant mechanism. The total amount of funding that the NIH expects to award through this announcement is $3 million to $5 million in fiscal year 2010; the anticipated number of awards is 13 to 16 awards, and this number will depend on the budgets and areas of institute/center interest of the awards made. The expected direct cost amount for individual awards is $200,000 to $250,000 per year, and the project period is 4 years. Deadline: 2010-01-11
- Department of Health and Human Services. National Institutes of Health
-
Human Brown Adipose Tissue: Methods for Measurement of Mass and Activity (R21)
This funding opportunity announcement (FOA) issued by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institutes of Biomedical Imaging and Bioengineering, National Institutes of Health (NIH), solicits applications for Exploratory/Development Research Grants (R21) to develop tools and methods capable of measuring the mass of brown adipose tissue (BAT) in human populations (e.g., amounts in different depots, amounts mixed in with white adipose tissue and muscle); to develop new tools to modulate and measure the metabolic activity of human BAT, or to develop additional markers of human BAT tissue mass or activity. This FOA will utilize the NIH Exploratory/Development Research (R21) grant mechanism. The total amount of funding that the institute/center expects to award through this announcement is up to $3.45 million, to fund approximately 10 to 12 awards. The total project period for an application submitted in response to this funding opportunity may not exceed 2 years. Direct costs are limited to $275,000 over the 2 years of the R21 award, with no more than $200,000 in direct costs allowed in any single year. Applicants may request direct costs in $25,000 modules, up to the total direct costs limitation of $275,000 for the combined 2-year award period. Deadline: 2010-02-10
- Human Frontier Science Program Organization.
-
Human Frontier Science Program Organization Research Grants
Research grants are provided for teams of scientists from different countries who wish to combine their expertise to approach questions that could not be answered by individual laboratories. Emphasis is placed on novel collaborations that bring together scientist from different disciplines (e.g., from chemistry, physics, computer science, engineering) to focus on problems in the life sciences. The research teams must be international. The principal applicant must be from one of the eligible countries. However, other participating scientists and laboratories may be situated anywhere in the world. Applicants must register for a password by 22 March 2010. Applicants must submit a letter of intent by 31 March 2010 to apply for a research grant via the Human Frontier Science Program Organization Web site. Program grants are awarded to teams of independent researchers at any stage of their careers. The research team is expected to develop new lines of research through the collaboration. Up to $450,000 per grant, per year may be allowed. Applications including independent investigators early in their careers are encouraged. Deadline: 2010-03-22
- India Alliance Wellcome Trust/ DBT India Alliance.
-
Early Career Fellowships for Researchers in India
The Wellcome Trust/Department of Biotechnology India Alliance is calling for fellowship applications from newly qualified postdoctoral researchers who wish to make an early start in launching their independent research career in India. Applicants in their last year of Ph.D. or with up to 12 months postdoctoral research experience may apply. The fellowships are for 4 years and provide competitive personal support for the fellow, generous funding for research consumables, and funding to work overseas. Preliminary applications are due by 25 January 2010. For more information and the preliminary application form, please visit www.wellcomedbt.org. Deadline: 2010-01-25
- IQ Solutions Inc.
-
Distinguished International Scientist Collaboration Program
Through the Distinguished International Scientist Collaboration Program, the National Institute on Drug Abuse (NIDA) seeks to enhance international collaborative research on drug abuse and drug-related consequences. The competitive Distinguished International Scientist Collaboration Awards (DISCA) and the Distinguished International Scientist Collaboration Awards for U.S. Citizens and Permanent Residents (USDISCA) invite senior researchers from other countries and NIDA grantees to apply to work together in the most suitable locale for their joint research. The program allows participants to choose the travel option that works best for their research. If the project would best be conducted outside the United States, NIDA grantees should apply for a USDISCA award to visit their partner's home country. If the project would best be conducted in the United States, international drug-abuse researchers should apply for a DISCA award to visit their U.S. partners. Successful candidates will be highly qualified researchers, and priority will be given to new collaborations. Applicants must propose an innovative approach to projects that fall within the NIDA research mission, clearly define their expected product or outcome, and submit a final report to NIDA. DISCA and USDISCA awards provide (1) a research exchange visit lasting from 1 to 3 months, depending upon the project requirements; (2) a monthly allowance of $6500 to cover short-term living expenses in the host country; and (3) one round trip between the home and host cities for the scientist only. Visas and health insurance are the responsibility of the awardee. Deadline: 2010-01-01
- IQ Solutions Inc.
-
INVEST/CTN Drug Abuse Research Fellowship
In addition to the normal cohort of INVEST fellows, the National Institute on Drug Abuse International Program and Clinical Trials Network (CTN) are joining forces to offer INVEST/CTN fellowships to non-U.S. scientists who will work with a mentor affiliated with one of the 16 CTN Regional Research and Training Centers. The INVEST/CTN Drug Abuse Research Fellowship combines postdoctoral research training in the United States with professional development activities and grant-writing guidance to form a unique program for drug-abuse scientists. Fellows may conduct their research in any aspect of the CTN research agenda on drug abuse and addiction, such as intervention research, clinical trials methodology, or drug-abuse treatment as HIV/AIDS prevention. Fellows and their mentors are encouraged to develop jointly and seek funding for a collaborative research project to be conducted in the fellow's home country. Fellows and their U.S. mentors are part of a network of international scientists who exchange information and collaborate on drug-abuse research nationally, regionally, and globally. The 12-month fellowship provides rigorous postdoctoral research training with a National Institute on Drug Abuse (NIDA) grantee at one of the 16 CTN Regional Research and Training Centers. The program also provides professional development activities that help establish personal relationships with NIDA grantees and NIDA officials who are willing to continue working with fellows after they return home. Fellows will be provided with a stipend of $39,000 for living and personal expenses, and roundtrip travel and a $5000 allowance to cover the cost of health insurance and professional development activities. Deadline: 2010-09-01
- IQ Solutions Inc.
-
INVEST Drug Abuse Research Fellowship (INVEST)
The INVEST Drug Abuse Research Fellowship combines postdoctoral research training in the United States with professional development activities and grant-writing guidance to form a unique program for drug-abuse scientists. Fellows may conduct their research in any aspect of the biomedical or behavioral science of drug abuse and addiction. Previous fellows have conducted research in all aspects of drug abuse and addiction, from social science to basic science, including epidemiology, prevention, treatment, and preclinical and clinical sciences. Fellows and their mentors are encouraged to develop jointly and seek funding for a collaborative research project to be conducted in the fellow's home country. Fellows and their U.S. mentors are part of a network of international scientists who exchange information and collaborate on drug-abuse research nationally, regionally, and globally. The 12-month fellowship provides rigorous postdoctoral research training with a National Institute on Drug Abuse (NIDA) grantee at a U.S. institution. The fellowship also provides professional-development activities that help fellows establish personal relationships with NIDA grantees and NIDA officials who are willing to continue working with them after they return home. Fellows will be provided with a stipend of $39,000 for living and personal expenses and roundtrip travel and a $5000 allowance to cover the cost of health insurance and professional development activities. Deadline: 2010-04-01; 2010-10-01
GrantsNet Express
GrantsNet Express offers a new listing each week by e-mail of science funding opportunities from private foundations and organizations, as well as new U.S. government science grant announcements.
Deadline Watch
(Image: comstock)
- Department of Health and Human Services. National Institutes of Health
-
Technologies for Image-Guided Interventions (R01)
Deadline: 2009-12-20
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2009-12-21
- Department of Health and Human Services. National Institutes of Health
-
NHLBI Centers for Cardiovascular Outcomes Research (U01)
Deadline: 2009-12-21
- Department of Health and Human Services. National Institutes of Health
-
NHLBI Cardiovascular Outcomes Research Coordinating Unit (U01)
Deadline: 2009-12-21
- Department of Health and Human Services. National Institutes of Health
-
Reducing Cardiovascular Disease Risk Through Treatment of Obstructive Sleep Apnea (U34)
Deadline: 2009-12-21
- Nuclear Regulatory Commission.
-
Deadline: 2009-12-22
- Department of Health and Human Services. National Institutes of Health
-
State and Community Tobacco Control Policy and Media Research (U01)
Deadline: 2009-12-22
- Department of Health and Human Services. National Institutes of Health
-
Roadmap Transformative Research Projects Program (R01)
Deadline: 2009-12-22
- National Science Foundation.
-
NIBIB Quantum Projects: Implementation Phase II (U01)
Deadline: 2009-12-22
- Department of Health and Human Services. National Institutes of Health
-
Engineered Nanomaterials: Linking Physical and Chemical Properties to Biology (U19)
Deadline: 2009-12-22
- Department of Health and Human Services. Agency for Health Care Research and Quality
-
Medical Liability Reform and Patient Safety Planning Grants (R21)
Deadline: 2009-12-23
- Department of Health and Human Services. Agency for Health Care Research and Quality
-
Medical Liability Reform and Patient Safety Demonstration Projects (R18)
Deadline: 2009-12-23
- Department of Defense.
-
FY09 DOD Lung Cancer Biospecimen Resource Network Award
Deadline: 2009-12-23
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2009-12-28; 2010-04-20; 2010-08-21; 2010-12-20
- National Science Foundation.
-
Postdoctoral Fellowships in Polar Regions Research
Deadline: 2009-12-28; 2010-10-18; 2011-10-18
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2009-12-30; 2010-08-30
- Keystone Symposia.
-
Underrepresented Minority Scholarships
Deadline: 2009-12-31
- Department of Defense.
-
High School Apprenticeship Program (HSAP)
Deadline: 2009-12-31
- National Aeronautics and Space Administration.
-
Deadline: 2009-12-31
- Damon Runyon Cancer Research Foundation.
-
Damon Runyon Postdoctoral Fellowship
Deadline: 2009-12-31
- Doris Duke Charitable Foundation.
-
2009 Innovation in Clinical Research Award
Deadline: 2009-12-31
- National Postdoctoral Association.
-
Inaugural Award Recognizing Scientific Entrepreneurs
Deadline: 2009-12-31
- Octapharma USA Inc..
-
Grants Program to Support Research on Immunology, Coagulation Disorders, and Critical Care
Deadline: 2009-12-31
- Alexander von Humboldt Foundation.
-
Humboldt Research Fellowship for Experienced Researchers
Deadline: 2009-12-31
- Alexander von Humboldt Foundation.
-
Humboldt Research Fellowship for Postdoctoral Researchers
Deadline: 2009-12-31
- The Michael J. Fox Foundation for Parkinson's Research.
-
Rapid Response Innovation Awards
Deadline: 2009-12-31
- National Science Foundation.
-
Atomic Molecular and Optical Physics
Deadline: 2009-30-09
- IQ Solutions, Inc.
-
Distinguished International Scientist Collaboration Program
Deadline: 2010-01-01
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2010-01-01
- Department of Health and Human Services. National Institutes of Health
-
Neurobiology of Adolescent Drinking in Adulthood (NADIA)(U01 and U24)
Deadline: 2010-01-02
- Department of Health and Human Services. National Institutes of Health
-
Development of New Tools for Computational Analysis of Human Microbiome Project Data (R21)
Deadline: 2010-01-04
- Alliance for Cancer Gene Therapy (ACGT).
-
Young Investigator Award Research Grant
Deadline: 2010-01-04
- Environmental Protection Agency.
-
Deadline: 2010-01-04
- Department of Health and Human Services. National Institutes of Health
-
Deadline: 2010-01-04; 2011-01-04; 2012-01-04
- Department of Health and Human Services. National Institutes of Health
-
Dissemination and Implementation Research in Health (R01)
Deadline: 2010-01-05; 2010-05-05; 2010-09-05
- National Science Foundation.
-
Deadline: 2010-01-07
- Alzheimer's Drug Discovery Foundation.
-
Novel Approaches to Drug Discovery for Alzheimer's Disease
Deadline: 2010-01-07
- Environmental Protection Agency.
-
Approaches to Assessing Potential Food Allergy from Genetically Engineered Plants
Deadline: 2010-01-07
- Department of Health and Human Services. National Institutes of Health
-
Phased Innovation Award Program for AIDS Vaccine Research (R21/R33)
Deadline: 2010-01-07
- American Brain Tumor Association.
-
Deadline: 2010-01-08
- American Brain Tumor Association.
-
Deadline: 2010-01-08
- Alliance for Academic Internal Medicine.
-
Deadline: 2010-01-08
- National Science Foundation.
-
Deadline: 2010-01-09; 2010-07-09
- National Science Foundation.
-
Population and Community Ecology
Deadline: 2010-01-09; 2010-07-09
- National Aeronautics and Space Administration. NASA Headquarters
-
Experimental Program to Stimulate Competitive Research (EPSCoR)
Deadline: 2010-01-11
- Department of Health and Human Services. National Institutes of Health
-
Membrane Protein Production for Structure Determination (R01)
Deadline: 2010-01-11
- National Science Foundation.
-
Deadline: 2010-01-12
- National Science Foundation.
-
Deadline: 2010-01-12
- Alliance for Academic Internal Medicine.
-
ASP-American Heart Association Career Development Award in Geriatric Cardiology
Deadline: 2010-01-13
- National Science Foundation.
-
Deadline: 2010-01-13
- National Science Foundation.
-
Tribal Colleges and Universities Program
Deadline: 2010-01-14
- Department of Agriculture.
-
Specialty Crop Research Initiative
Deadline: 2010-01-14
- National Science Foundation.
-
Deadline: 2010-01-14
- National Science Foundation.
-
Planetary Biodiversity Inventories
Deadline: 2010-01-14
- American Federation for Aging Research.
-
Beeson Career Development Awards (BCDA)
Deadline: 2010-01-14
- Department of Agriculture. National Institute of Food and Agriculture
-
Specialty Crop Research Initiative
Deadline: 2010-01-14
- Alliance for Academic Internal Medicine.
-
ADA-ASP Young Investigator Innovation Award in Geriatric Endocrinology
Deadline: 2010-01-15
- The National Bureau of Asian Research.
-
Deadline: 2010-01-15
- Department of Agriculture.
-
Deadline: 2010-01-15
- Parkinson's Disease Foundation.
-
Parkinson's Disease Foundation Student Summer Fellowship
Deadline: 2010-01-15
- Parkinson's Disease Foundation.
-
Deadline: 2010-01-15
- Department of Health and Human Services. National Institutes of Health
-
Dissemination and Implementation Research in Health (R21)
Deadline: 2010-01-16; 2010-05-16; 2010-09-16
- Department of Health and Human Services. National Institutes of Health
-
Dissemination and Implementation Research in Health (R03)
Deadline: 2010-01-16; 2010-05-16; 2010-09-16
GrantsNet Sponsorship
Sponsorship opportunities are now available on GrantsNet and GrantsNet Express. Please contact Daryl Anderson for more information.
[ top ]
Donisha Adams is the GrantsNet Program Associate. | |
10.1126/science.caredit.f20091218 |
